ASUSTeK Computer Inc. (LUX:ACMRS)

CTI BioPharma Revenue

ASUSTeK Computer had revenue of 147.69B TWD in the quarter ending March 31, 2025, with 21.36% growth. This brings the company's revenue in the last twelve months to 613.08B, up 24.46% year-over-year. In the year 2024, ASUSTeK Computer had annual revenue of 587.09B with 21.72% growth.

• Revenue (ttm): 613.08B TWD
• Revenue Growth: +24.46%
• P/S Ratio: 0.84
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 14.36B USD

Revenue Chart

* This company reports financials in TWD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	587.09B	104.77B	21.72%
Dec 31, 2023	482.31B	-54.88B	-10.22%
Dec 31, 2022	537.19B	1.95B	0.36%
Dec 31, 2021	535.24B	122.46B	29.67%
Dec 31, 2020	412.78B	61.45B	17.49%